Lawrence Kwong
Associate Professor
The University of Texas MD Anderson Cancer Center
Department of Translational Molecular Pathology
Our lab focuses primarily on cholangiocarcinoma (bile duct cancer), melanoma, and bladder cancer, with an emphasis on drug resistance, discovery of novel drug combinations, mouse modeling, patient sample analyses, and omics including RNAseq, ChIPseq, spatial transcriptomics, single cell RNAseq, and proteomics. Examples of ongoing projects include a novel synergistic drug co-target for FGFR3 inhibition in bladder cancer, lineage plasticity exploration in cholangiocarcinoma and its correlation with survival and drug responses, and the harnessing of therapeutic senescence induction in melanoma to enhance cell killing. A student in our lab will learn cell culture, mouse modeling, patient sample handling, basic bioinformatics, and much more.
Education & Training
Ph.D. - University of Wisconsin-Madison - 2006